成人先天性心疾患パーフェクトガイド

出版社： 文光堂
著者：
発行日： 2015-09-01
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784830619274
電子書籍版： 2015-09-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

11,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

11,000 円(税込)

購入する

商品紹介

小児期に手術を受け，一見良くなったように見えても，加齢に伴い，心機能悪化，心不全，不整脈，突然死などにより，生命予後が修飾されることがあります．また，就業，結婚，出産，遺伝，社会心理的問題などの成人期特有の対応すべき問題もあります．そのような背景からさまざまな症状に対応し，致命的な問題が起きないようにマネジメント（管理）していくために，診療科の枠を越えたチーム医療の構築が急がれております．循環器系の診療科はもちろん，消化器系，精神科なども含めた複数の診療科と，コメディカルスタッフで構成された専門家チームによる診療体制のあり方を示す重要な1冊です．

目次

  • 成人先天性心疾患パーフェクトガイド

    ―目次―

    I なぜ今，成人先天性心疾患？
    　1 これから激増する成人先天性心疾患
    　2 小児科から循環器内科への橋渡しの重要性と問題点
    　3 成人先天性心疾患の画像診断
    　　a　経胸壁心エコー図
    　　b 経食道心エコー図
    　　c CT，MRI
    　4 成人先天性心疾患の血行動態評価─カテーテル検査─
    　5 チアノーゼ型先天性心疾患における多臓器不全と自然歴
    　　　（非手術歴）
    　6 Eisenmenger症候群の管理と治療
    　7 成人先天性心疾患の遺伝学

    II 知っておくべき手術
    　　─血行動態，画像診断，遠隔期問題，そして対策─
    　1 Fontan手術の歴史と遠隔期の問題，再手術
    　2 Fontan手術後
    　　a 肝臓病変・代謝異常
    　　b 消化管・蛋白漏出性胃腸症
    　3 Rastelli手術とは─遠隔期の問題と再手術─
    　4 Senning／Mustard手術とは─遠隔期の問題と再手術─
    　5 Jatene手術とは─遠隔期の問題と再手術─
    　6 Norwood手術とは─歴史と今後の問題─
    　7 ダブルスイッチ手術とは─適応と遠隔期の問題─
    　8 unifocalizationとは─適応と遠隔期の問題─
    　9 Fallot四徴術後─遠隔期の問題と再手術─
    　10 房室中隔欠損症─遠隔期の問題と再手術─

    III 未治療の成人先天性心疾患の病態と治療
    　1 心房中隔欠損症
    　2 卵円孔開存症
    　3 心室中隔欠損症，Valsalva洞動脈瘤破裂
    　4 動脈管開存症
    　5 Ebstein病
    　6 修正大血管転位症
    　7 川崎病性冠動脈瘤
    　8 大動脈縮窄症
    　9 Marfan症候群

    IV 成人先天性心疾患に対する最新の治療
    　1 心不全
    　　a 薬物療法
    　　b 運動療法・リハビリテーション
    　2 不整脈
    　　a 薬物療法
    　　b アブレーション
    　　c デバイス治療
    　3 肺高血圧症
    　　a 薬物療法
    　　b 肺移植

    V 成人先天性心疾患の妊娠・出産
    　1 妊娠・出産にどのように対応するか？
    　2 妊娠中の薬物治療のポイントと禁忌薬
    　3 妊娠・出産時の麻酔管理
    　4 避妊法と不妊治療

    VI 成人先天性心疾患の全身管理
    　1 感染性心内膜炎
    　2 成人先天性心疾患と麻酔
    　3 精神・心理学的アプローチ
    　4 口腔感染管理

    VII 成人先天性心疾患の診療体制と今後
    　1 国内における診療体制の試み
    　2 海外における診療体制の試み

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I なぜ今, 成人先天性心疾患 ?

P.5 掲載の参考文献
1) Shiina, Y et al : Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011 ; 146 : 13-16
 
2) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年8月閲覧)
 
3) Terai, M et al : Mortality from congenital cardiovascular malformations in Japan, 1968 through 1997. Circ J 2002 ; 66 : 484-488
 
4) 白石公 : 成人期を迎えた先天性心疾患患者の諸問題. 京府医大誌 2010 ; 119 : 247-259
 
5) 丹羽公一郎ほか : 成人期先天性心疾患患者の社会的自立と問題点. J Cardiol 2002 ; 39 : 259-266
 
P.9 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
2) Shiina, Y et al : Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011 ; 146 : 13-16
 
3) Bouchardy, J et al : Atrial arrhythmias in adults with congenital heart disease. Circulation 2009 ; 120 : 1679-1686
 
4) Ochiai, R et al : Status and future needs of regional adult congenital heart disease centers in Japan. Circ J 2011 ; 75 : 2220-2227
 
5) Watanabe, N et al : Usefulness of the right parasternal approach to evaluate the morphology of atrial septal defect for transcatheter closure using twodimensional and three-dimensional transthoracic echocardiography. J Am Soc Echocardiogr 2012 ; 25 : 376-382
 
P.19 掲載の参考文献
1) Therrien, J et al : Pulmonary valve replacement in adults late after repair of tetralogy of Fallot : are we operating too late? J Am Coll Cardiol 2000 ; 36 : 1670-1675
 
2) Discigil, B et al : Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001 ; 121 : 344-351
 
3) Watanabe, N et al : Usefulness of the right parasternal approach to evaluate the morphology of atrial septal defect for transcatheter closure using two-dimensional and three-dimensional transthoracic echocardiography. J Am Soc Echocardiogr 2012 ; 25 : 376-382
 
4) Rebergen, SA et al : Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993 ; 88 : 2257-2266
 
5) Goldberg, SJ et al : Quantitative assessment by Doppler echocardiography of pulmonary or aortic regurgitation. Am J Cardiol 1985 ; 56 : 131-135
 
6) Renella, P et al : Two-dimensional and Doppler echocardiography reliably predict severe pulmonary regurgitation as quantified by cardiac magnetic resonance. J Am Soc Echocardiogr 2010 ; 23 : 880-886
 
7) Rudski, LG et al : Guidelines for the echocardiographic assessment of the right heart in adults : a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010 ; 23 : 685-713 ; quiz 786-788
 
P.25 掲載の参考文献
1) Ayres, NA et al : Indications and guidelines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease. J Am Soc Echocardiogr 2005 ; 18 : 91-98
PubMed
2) Hahn, RT et al : Guidelines for performing a comprehensive transesophageal echocardiographic examination : recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2013 ; 26 : 921-964
 
3) Taniguchi, M et al : Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J Am Soc Echocardiogr 2009 ; 22 : 1114-1120
 
4) van den Bosch, AE et al : Characterization of atrial septal defect assessed by real-time 3-dimensional echocardiography. J Am Soc Echocardiogr 2006 ; 19 : 815-821
 
5) Amin, Z : Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2006 ; 68 : 778-787
 
6) Kijima, Y et al : Three-dimensional echocardiography guided closure of complex multiple atrial septal defects. Echocardiography 2014 ; 31 : E304-E306
 
P.31 掲載の参考文献
1) Yamasaki, Y et al : Prosthetic valve dysfunction in repaired tetralogy of Fallot : assessment by FDG-PET and 256-slice 4D-CT. Eur Heart J Cardiovasc Imaging 2014 ; 15 : 1303
PubMed
2) Nagao, M et al : Interventricular dyssynchrony using tagging magnetic resonance imaging predicts right ventricular dysfunction in adult congenital heart disease. Congenit Heart Dis 2015 ; 10 : 271-280
 
3) Kondo, M et al : Improvement of automated right ventricular segmentation using dual-bolus contrast media injection with 256-slice coronary CT angiography. Acad Radiol 2014 ; 21 : 648-653
 
4) Yamasaki, Y et al : Quantitative assessment of right ventricular function and pulmonary regurgitation in surgically repaired tetralogy of Fallot using 256-slice CT : comparison with 3 Tesla MRI. Eur Radiol 2014 ; 24 : 3289-3299
 
5) Sakamoto, I et al : Giant pulsatile coronary aneurysms associated with pulmonary atresia with an intact ventricular septum after a Fontan procedure. Circulation 2014 ; 130 : e121-e123
 
P.35 掲載の参考文献
1) Giannakoulas, G et al : Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol 2009 ; 103 : 1445-1450
 
2) Shimizu, S et al : Intracardiac echocardiography for percutaneous closure of atrial septal defects : initial experiences in Japan. Cardiovasc Interv Ther 2013 ; 28 : 368-373
 
P.40 掲載の参考文献
1) Perloff, JK : Cyanotic congenital heart disease : a multisystem disorder. Congenital Heart Disease in Adults, 3nd ed, Perloff, JK et al eds, WB Saunders, Elsevier, Philadelphia, 2009, 1265-1289
 
2) Niwa, K et al : Eisenmenger syndrome in adults. ventricular septal defect, truncus arteriosus and univentricular hearts. J Am Coll Cardiol 1999 ; 34 : 223-232
 
3) Silversides, CK et al : Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003 ; 42 : 1982-1987
 
4) Hoffmann, A et al : Cerebrovascular accidents in adult patients with congenital heart disease. Heart 2010 ; 96 : 1223-1226
 
5) Burlet, A et al : Renal function in cyanotic congenital heart disease. Nephron 1998 ; 81 : 296-300
 
6) 長嶋正實ほか : チアノーゼ型先天性心疾患にみられる腎疾患の頻度, 成因解析と診断, 治療法の策定. 日小循誌 2006 ; 22 : 130-133
 
7) Shiina, Y et al : Prevalence and risk factors for cholelithiasis and asymptomatic gall stones in adults with congenital heart disease. Int J Cardiol 2011 ; 152 : 171-176
 
8) Oechslin, E et al : Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 2005 ; 112 : 1106-1112
 
9) Chugh, R et al : Extramural coronary arteries in adults with cyanotic congenital heart disease. Am J Cardiol 2004 ; 94 : 1355-1357
 
10) Fyfe, A et al : Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol 2005 ; 96 : 283-290
 
P.48 掲載の参考文献
1) Galie, N et al : Bosentan therapy in patients with Eisenmenger syndrome : a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006 ; 114 : 48-54
 
2) Dimopoulos, K et al : Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010 ; 121 : 20-25
 
3) Vongpatanasin, W et al : The Eisenmenger syndrome in adults. Ann Intern Med 1998 ; 128 : 745-755
 
4) Broberg, CS et al : Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007 ; 50 : 634-642
 
5) Sakazaki, H et al : Clinical features of adult patients with Eisenmenger's syndrome in Japan and Korea. Int J Cardiol 2013 ; 167 : 205-209
 
6) Barst, RJ et al : Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Am J Cardiol 2014 ; 113 : 147-155
 
7) Diller, GP et al : Survival prospects of treatment naive patients with Eisenmenger : a systematic review of the literature and report of own experience. Heart 2014 ; 100 : 1366-1372
 
8) Mebus, S et al : The adult patient with Eisenmenger syndrome : a medical update after Dana Point Part II : medical treatment-study results. Curr Cardiol Rev 2010 ; 6 : 356-362
 
9) Said, S et al : Eisenmenger syndrome : recent advances in pharmacotherapy. Cardiovasc Hematol Agents Med Chem 2013 ; 11 : 289-296
 
10) D'Alto, M et al : Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome : current advanced management strategies. Heart 2014 ; 100 : 1322-1328
 
11) Oechslin, E et al : The adult patient with Eisenmenger syndrome : a medical update after Dana Point Part III : specific management and surgical aspects. Curr Cardiol Rev 2010 ; 6 : 363-372
 
P.54 掲載の参考文献
1) 石崎怜奈ほか : 成因論と遺伝子異常. 先天性心疾患, 中澤誠編, メジカルビュー社, 東京, 2014, 5-15
 
2) 山岸敬幸ほか : 小児科医のための遺伝学, 先天性心疾患. 小児内科 2008 ; 40 : 1339-1345
 
3) 松岡瑠美子ほか : 先天性心疾患の疫学調査-1990年4月から1999年7月, 2,645家系の報告-. 日小児循環器会誌 2003 ; 19 : 606-621
 
4) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
5) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 心臓血管疾患における遺伝学的検査と遺伝カウンセリングに関するガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_nagai_h.pdf (2015年9月閲覧)
 
6) 安藤正彦 : 心臓血管系の疾患と遺伝学-主に先天性心疾患の遺伝相談. 小児科診療 1987 ; 50 : 868
 
7) 里見元義ほか : 胎児心エコー検査ガイドライン. 日小児循環器会誌 2006 ; 22 : 591-613
 

II 知っておくべき手術 - 血行動態, 画像診断, 遠隔期問題, そして対策 -

P.61 掲載の参考文献
1) Gewillig, M : The Fontan circulation. Heart 2005 ; 91 : 839-846
 
2) Fontan, F et al : Surgical repair of tricuspid atresia. Thorax 1971 ; 26 : 240-248
 
3) Bjork, VO et al : Right atrial-right ventricular anastomosis for correction of tricuspid atresia. J Thorac Cardiovasc Surg 1979 ; 77 : 452-458
 
4) de Leval, MR et al : Total cavopulmonary connection : a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988 ; 96 : 682-695
 
5) Marcelletti, C et al : Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg 1990 ; 100 : 228-232
 
6) Kumar, SP et al : Lateral tunnel versus extracardiac conduit Fontan procedure : a concurrent comparison. Ann Thorac Surg 2003 ; 76 : 1389-1396 ; discussion 1396-1397
 
7) Balaji, S et al : An international multicenter study comparing arrhythmia prevalence between the intracardiac lateral tunnel and the extracardiac conduit type of Fontan operations. J Thorac Cardiovasc Surg 2014 ; 148 : 576-581
 
8) Collins, KK : The spectrum of long-term electrophysiologic abnormalities in patients with univentricular hearts. Congenit Heart Dis 2009 ; 4 : 310-317
 
9) Anderson, PA et al : Contemporary outcomes after the Fontan procedure : a Pediatric Heart Network multicenter study. J Am Coll Cardiol 2008 ; 52 : 85-98
 
10) Shaddy, RE et al : Carvedilol for children and adolescents with heart failure : a randomized controlled trial. JAMA 2007 ; 298 : 1171-1179
 
11) Firdouse, M et al : Thrombosis and thromboembolic complications in Fontan patients : a literature review. Clin Appl Thromb Hemost 2014 ; 20 : 484-492
 
12) Monagle, P et al : A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 2011 ; 58 : 645-651
 
13) Mertens, L et al : Protein-losing enteropathy after the Fontan operation : an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998 ; 115 : 1063-1073
 
14) John, AS et al : Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014 ; 64 : 54-62
 
15) Costello, JM et al : Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator : a case report and review of the literature. Pediatrics 2002 ; 109 : e67
 
16) Srivastava, D et al : Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 1995 ; 92 : 1217-1222
 
P.68 掲載の参考文献
1) Khairy, P et al : Long-term survival, modes of death, and predictors of mortality in patients with fontan surgery. Circulation 2008 ; 117 : 85-92
PubMed
2) Gewillig, M : The Fontan circulation. Heart 2005 ; 91 : 839-846
 
3) Rychik, J et al : The precarious state of the liver after a Fontan operation : summary of a multidisciplinary symposium. Pediatr Cardiol 2012 ; 33 : 1001-1012
 
4) Asrani, SK et al : Hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013 ; 368 : 1756-1757
 
5) Wu, FM et al : Liver disease in the patient with Fontan circulation. Congenit Heart Dis 2011 ; 6 : 190-201
 
6) Tomkiewicz-Pajak, L et al : Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J Thorac Cardiovasc Surg 2014 ; 147 : 1284-1290
 
7) Guha, IN et al : Structural and functional uncoupling of liver performance in the Fontan circulation. Int J Cardiol 2013 ; 164 : 77-81
 
8) Hsia, TY et al : Subdiaphragmatic venous hemodynamics in the Fontan circulation. J Thorac Cardiovasc Surg 2001 ; 121 : 436-447
 
9) Kiesewetter, CH et al : Hepatic changes in the failing Fontan circulation. Heart 2007 ; 93 : 579-584
 
10) Bulut, OP et al : Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure. J Pediatr 2013 ; 163 : 201-206
 
11) Schwartz, MC et al : Hepatic pathology may develop before the Fontan operation in children with functional single ventricle : an autopsy study. J Thorac Cardiovasc Surg 2012 ; 143 : 904-909
 
12) Ohuchi, H et al : Comparison of prognostic variables in children and adults with Fontan circulation. Int J Cardiol 2014 ; 173 : 277-283
 
13) Barker, DJP : Fetal origins of coronary heart disease. BMJ 1995 ; 311 : 171-174
 
14) von Haehling, S et al : Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007 ; 73 : 298-309
 
15) Chiasson, JL et al : Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance : the STOP-NIDDM trial. JAMA 2003 ; 290 : 486-494
 
16) Billett, J et al : Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK : cross-sectional, population-based study with case-control analysis. Heart 2008 ; 94 : 1194-1199
 
17) Ohuchi, H et al : High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J 2009 ; 158 : 30-39
 
18) Ohuchi, H et al : Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease. Int J Cardiol 2014 ; 174 : 306-312
 
19) Whiteside, W et al : Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation. J Pediatr 2013 ; 162 : 1199-1204
 
P.71 掲載の参考文献
1) 桑田聖子ほか : 蛋白漏出性胃腸症 (PLE) の診断におけるグリコアルブミンの有用性. 日小児循環器会誌 2014 ; 30 : s229
 
2) 栗嶋クララほか : Fontan術後蛋白漏出性胃腸症とリンパ動態 リンパマッサージの有用性. 日小児循環器会誌 2014 ; 30 : s228
 
3) Rychik, J et al : Relation of mesenteric vascular resistance after Fontan operation and protein losing enteropathy. Am J Cardiol 2002 ; 90 : 672-674
 
4) Gursu, HA et al : Oral budesonide as a therapy for protein-losing enteropathy in children after the Fontan operation. J Card Surg 2014 ; 29 : 712-716
 
5) John, AS et al : Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol 2014 ; 64 : 54-62
 
P.79 掲載の参考文献
1) Rastelli, GC et al : Complete repair of transposition of the great arteries with pulmonary stenosis : a review and report of a case corrected by using a new surgical technique. Circulation 1969 ; 39 : 83-95
 
2) Chamaidi, A et al : Long-term outcome after rastelli repair. Cases in Adult Congenital Heart Disease, Gatzoulis, MA ed, Elsevier, Philadelphia, 2010, 299-304
 
3) Dearani, JA et al : Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003 ; 75 : 399-410 ; discussion 410-411
 
4) Isomatsu, Y et al : Establishing right ventricle-pulmonary artery continuity by autologous tissue : an alternative approach for prosthetic conduit repair. Ann Thorac Surg 2004 ; 78 : 173-180
 
5) Koh, M et al : Long-term outcome of right ventricular outflow tract reconstruction using a handmade tri-leaflet conduit. Eur J Cardiothorac Surg 2005 ; 27 : 807-814
 
6) Said, SM et al : Surgical considerations in adult patients with congenital heart disease. Cardiac CT and MR for Adult Congenital Heart Disease, Saremi, F ed, Springer, New York, 2014, 431-450
 
7) Tan, JL et al : Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot : evidence of causative mechanism for aortic dilatation and aortopathy. Circulation 2005 ; 112 : 961-968
 
8) Tateno, S et al : Risk factors for arrhythmia and late death in patients with right ventricle to pulmonary artery conduit repair-Japanese multicenter study. Int J Cardiol 2006 ; 106 : 373-381
 
9) Duncun, BW et al : Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2003 ; 126 : 694-702
 
10) Luiz, PC et al : Pulmonic valve implantation in adults. Structural Heart Disease Interventions, Destefano, F ed, Lippincott Williams & Wilkins, Philadelphia, 2012, 349-364
 
P.85 掲載の参考文献
1) Love, BA et al : Evaluation and management of the adult patient with transposition of the great arteries following atrial-level (Senning or Mustard) repair. Nat Clin Pract Cardiovasc Med 2008 ; 5 : 454-467
PubMed
2) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
3) Oechslin, E et al : 40 years after the first atrial switch procedure in patients with transposition of the great arteries : long-term results in Toronto and Zurich. J Thorac Cardiovasc Surg 2000 ; 48 : 233-237
 
4) Moons, P et al : Long term outcome up to 30 years after the Mustard or Senning operation : a nationwide multicentre study in Belgium. Heart 2004 ; 90 : 307-313
PubMed
5) Dos, L et al : Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 2005 ; 91 : 652-656
 
6) Kammeraad, JA et al : Predictors of sudden cardiac death after Mustard or Senning repair for trasnposition of the great arteries. J Am Coll Cardiol 2004 ; 44 : 1095-1102
PubMed
7) Ebenroth, ES et al : Late onset of pulmonary hypertension after successful Mustard surgery for dtransposition of the great arteries. Am J Cardiol 2000 ; 85 : 127-130
 
8) 富松宏文 : Senning手術, Mustard手術術後管理. 心エコー 2011 ; 11 : 760-766
 
9) Robinson, B et al : Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol 2002 ; 23 : 618-623
 
10) Janousek, J et al : Cardiac resynchronization therapy : a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol 2004 ; 44 : 1927-1931
 
P.90 掲載の参考文献
1) Mavroudis, C et al : Transposition of the great arteries. Pediatric Cardiac Surgery, 4th ed, Mavroudis C, et al eds, Wiley-Blackwell, West Sussex, 2013, 492-529
 
2) Kouchoukos, NT et al : Complete transposition of the great arteries. Kirklin/Barratt-Boyes Cardiac Surgery : Morphology, Diagnostic Criteria, Natural History, Techniques, Results, and Indications, 4th ed, Elsevier Saunders, Philadelphia, 2013
 
3) 坂本喜三郎 : Jatene 手術. 心臓血管外科テクニック IV 先天性心疾患編, 坂本喜三郎編, メディカ出版, 大阪, 2009, 210-215
 
4) Legendre, A et al : Coronary events after arterial switch operation for transposition of the great arteries. Circulation 2003 ; 108 : II-186-II-190
 
5) Nogi, S et al : Fate of the neopulmonary valve after the arterial switch operation in neonates. J Thorac Cardiovasc Surg 1998 ; 115 : 557-562
 
6) Williams, WG et al : Outflow obstruction after the arterial switch operation : a multiinstitutional study. Congenital Heart Surgeons Society. J Thorac Cardiovasc Surg 1997 ; 114 : 975-987 ; discussion 987-990
 
7) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
8) Schwartz, ML et al : Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation 2004 ; 110 : II-128-II-132
 
9) Hayashi, G et al : Prevalence of arrhythmias and their risk factors mid- and long-term after the arterial switch operation. Pediatr Cardiol 2006 ; 27 : 689-694
 
10) Tobler, D et al : Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 2010 ; 56 : 58-64
 
P.95 掲載の参考文献
1) Norwood, WI et al : Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983 ; 308 : 23-26
 
2) Jacobs, JP et al : Management of 239 patients with hypoplastic left heart syndrome and related malformations from 1993 to 2007. Ann Thorac Surg 2008 ; 85 : 1691-1697
PubMed
3) Kitahori, K et al : Precise evaluation of bilateral pulmonary artery banding for initial palliation in highrisk hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2010 ; 140 : 1084-1091
 
4) Sano, S et al : Risk factors for mortality artery the Norwood procedure using right ventricle to pulmonary artery shunt. Ann Thorac Surg 2009 ; 87 : 178-186
 
5) Sano, S et al : Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003 ; 126 : 504-510
 
6) Kataoka, K et al : The hemodynamic change of RV-PA shunt in modified Norwood procedure for HLHS and its equivalent hearts. Cardiol Young 2001 ; 11 (suppl 1) : 133
 
7) Ohye, RG et al : Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg 2008 ; 136 : 968-975
 
8) Ohye, RG et al : Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010 ; 362 : 1980-1992
 
P.99 掲載の参考文献
1) Ilbawi, MN et al : An alternative approach to the surgical management of physiologically corrected transposition with ventricular septal defect and pulmonary stenosis or atresia. J Thorac Cardiovasc Surg 1990 ; 100 : 410-415
 
2) Ferencz, C et al : Congenital heart disease : prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985 ; 121 : 31-36
 
3) Losekoot, TG et al : Congenitally Corrected Transposition, Charchihill Livingstone, Edinburgh, 1983, 21-41
 
4) Lim, HG et al : Outcomes of biventricular repair for congenitally corrected transposition of the great arteries. Ann Thorac Surg 2010 ; 89 : 159-167
PubMed
5) Shin'oka, T et al : Outcomes of definitive surgical repair for congenitally corrected transposition of the great arteries or double outlet right ventricle with discordant atrioventricular connections : Risk analyses in 189 patients. J Thorac Cardiovasc Surg 2007 ; 133 : 1318-1328
PubMed
6) Quinn, DW et al : The morphologic left ventricle that requires training by means of pulmonary artery banding before the double-switch procedure for congenitally corrected transposition of the great arteries is at risk of late dysfunction. J Thorac Cardiovasc Surg 2008 ; 135 : 1137-1144
 
7) 笠原真悟ほか : 先天性心疾患患者における導管による右室流出路再建術の検討. 循環器専門医 2011 ; 19 : 291-295
 
8) Lacour-Gayet, F et al : Biventricular repair of double outlet right ventricle with non-committed ventricular septal defect (VSD) by VSD rerouting to the pulmonary artery and arterial switch. Eur J Cardiothorac Surg 2002 ; 21 : 1042-1048
 
9) Fujii, Y et al : The impact of the length between the top of the interventricular septum and the aortic valve on the indications for a biventricular repair in patients with a transposition of the great arteries or a double outlet right ventricle. Interact Cardiovasc Thorac Surg 2010 ; 10 : 900-905 ; discussion 905
PubMed
10) da Silva, JP et al : Pulmonary root translocation in malposition of great arteries repair allows right ventricular outflow tract growth. J Thorac Cardiovasc Surg 2012 ; 143 : 1292-1298
 
11) Tateishi, A et al : The effect of pulmonary root translocation on the left ventricular outflow tract. Ann Thorac Surg 2013 ; 96 : 1469-1471
 
P.106 掲載の参考文献
1) 山村健一郎ほか : Fallot四徴, 肺動脈閉鎖, 主要体肺側副動脈. 先天性心疾患, 中澤誠編, メジカルビュー社, 東京, 2014, 208-215
 
2) 麻生俊英 : 主要体肺側副動脈, 心室中隔欠損を伴う肺動脈閉鎖-unifocalization. 先天性心疾患手術書, 安井久喬編, メジカルビュー社, 東京, 2003, 145-149
 
3) Haworth, SG et al : Pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Effect of systemic pulmonary anastomosis. Heart 198 ; 45 : 133-141
 
4) Kouchoukos, NT et al : Kirklin JW/Barratt' Cardiac Surgery, 4th ed, Churchill Livingstone, New York, 2013, 1359-1467
 
5) Malhorta, SP et al : Surgical management of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals : a protocol-based approach. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009 ; 12 : 145-151
 
6) Ishibashi, N et al : Clinical results of staged repair with complete unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Eur J Cardiothorac Surg 2007 ; 32 : 202-208
 
7) Cho, JM et al : Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2002 ; 124 : 70-81
PubMed
8) Yamamura, K et al : Efficacy of bosentan therapy for segmental pulmonary artery hypertension due to major aortopulmonary collateral arteries in children. Int J Cardiol 2012 ; 161 : e1-3
 
9) 山村健一郎 : Fallot四徴症, 肺動脈閉鎖. 成人先天性心疾患の心エコー, 丹羽浩一郎ほか編, ベクトル・コア社, 東京, 2014, 100-111
 
10) Maskatia, SA et al : Effect of branch pulmonary artery stenosis on right ventricular volume overload in patients with tetralogy of fallot after initial surgical repair. Am J Cardiol 2013 ; 111 : 1355-1360
 
P.114 掲載の参考文献
1) Nakazawa, M et al : Arrhythmias late after repair of tetralogy of Fallot : a Japanese Multicenter Study. Circ J 2004 ; 68 : 126-130
 
2) Khairy, P et al : Arrhythmia burden in adults with surgically repaired tetralogy of Fallot : a multi-institutional study. Circulation 2010 ; 122 : 868-875
 
3) Shimazaki, Y et al : The natural history of isolated congenital pulmonary valve incompetence : surgical implications. Thorac Cardiovasc Surg 1984 ; 32 : 257-259
 
4) Gatzoulis, MA et al : Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot. A multicentre study. Lancet 2000 ; 356 : 975-981
 
5) Therrien, J et al : Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005 ; 95 : 779-782
 
6) Mah, DY et al : The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol 2011 ; 22 : 1013-1017
 
7) Zeppenfeld, K et al : Catheter ablation of ventricular tachycardia after repair of congenital heart disease : electroanatomic identification of the critical right ventricular isthmus. Circulation 2007 ; 116 : 2241-2252
 
8) Khairy, P et al : Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008 ; 117 : 363-370
 
9) Khairy, P et al : PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm 2014 ; 11 : e102-e165
 
10) Niwa, K et al : Structural abnormalities of great arterial walls in congenital heart disease : light and electron microscopic analyses. Circulation 2001 ; 103 : 393-400
 
P.122 掲載の参考文献
1) Anderson, RH et al : The morphology and diagnosis of atrioventricular septal defects. Cardiol Young 1991 ; 1 : 290-305
 
2) Harmandar, B et al : Results for surgical correction of complete atrioventricular septal defect : associations with age, surgical era, and technique. J Card Surg 2012 ; 27 : 745-753
 
3) Myers, PO et al : Improving left ventricular outflow tract obstruction repair in common atrioventricular canal defects. Ann Thorac Surg 2012 ; 94 : 599-605 ; discussion 605
PubMed
4) Moran, AM et al : Surgical management of mitral regurgitation after repair of endocardial cushion defects : early and midterm results. Circulation 2000 ; 102 (19 Suppl 3) : III160-III165
 
5) Baumgartner, H et al : ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010 ; 31 : 2915-2957
 

III 未治療の成人先天性心疾患の病態と治療

P.130 掲載の参考文献
1) Campbell, M et al : Natural history of atrial septal defect. Heart 1970 ; 32 : 820-826
 
2) Murphy, JG et al : Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990 ; 323 : 1645-1650
 
3) Gatzoulis, MA et al : Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999 ; 340 : 839-846
 
4) Nakagawa, K et al : Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012 ; 80 : 84-90
 
5) Akagi, T : Current concept of transcatheter closure of atrial septal defect in adults. J Cardiol 2014 [Epub ahead of print]
 
6) Taniguchi, M et al : Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J Am Soc Echocardiogr 2009 ; 22 : 1114-1120
 
7) Baumgartner, H et al : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
8) Taniguchi, M et al : Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Catheter Cardiovasc Interv 2009 ; 73 : 682-686
 
9) Takaya, Y et al : Long-term outcome after transcatheter closure of atrial septal defect in older patients : impact of age at procedure. JACC Cardiovasc Interv 2015 ; 8 : 600-606
 
10) Amin, Z et al : Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects : review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004 ; 63 : 496-502
 
P.135 掲載の参考文献
1) Hagen, PT et al : Incidence and size of patent foramen ovale during the first decades of life : an autopsy study of 965 normal hearts. Mayo Clin Proc 1984 ; 59 : 17-20
PubMed
2) Lechat, P et al : Prevalence of patent foramen ovale in patient with stroke. N Engl J Med 1988 ; 318 : 1148-1152
 
3) Homma, S et al : Effect of medical treatment in stroke patients with patent foramen ovale : patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002 ; 105 : 2625-2631
 
4) Bridges, ND et al : Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992 ; 86 : 1902-1908
 
5) Carroll, JD et al : Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013 ; 368 : 1092-1100
 
6) Rengifo-Moreno, P et al : Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events : a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2013 ; 34 : 3342-3352
 
7) Azarbal, B et al : Association of interatrial shunts and migraine headaches : impact of transcatheter closure. J Am Coll Cardiol 2005 ; 45 : 489-492
 
8) Wahl, A et al : Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2010 ; 96 : 967-973
 
9) Garg, P et al : Lack of association between migraine headache and patent foramen ovale : results of a case-control study. Circulation 2010 ; 121 : 1406-1412
 
10) Dowson, A et al : Migraine Intervention With STARFlex Technology (MIST) trial : a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 ; 117 : 1397-1404
 
P.141 掲載の参考文献
1) Neumayer, U et al : Small ventricular septal defects in adults. Eur Heart J 1998 ; 19 : 1573-1582
 
2) Gabriel, HM et al : Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol 2002 ; 39 : 1066-1071
PubMed
3) Dimopoulos, K et al : Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010 ; 121 : 20-25
 
4) Penny, DJ et al : Ventricular septal defect. Lancet 2011 ; 377 : 1103-1112
 
5) Tweddell, JS et al : Ventricular septal defect and aortic valve regurgitation : pathophysiology and indications for surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006 ; 9 : 147-152
 
6) Baumgartner, H et al : ESC guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
P.145 掲載の参考文献
1) Krichenko, A et al : Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlua sion. Am J Cardiol 1989 ; 63 : 877-880
 
2) Schneider, DJ et al : Patent ductus arteriosus. Circulation 2006 ; 114 : 1873-1882
 
3) Campbell, M : Natural history of persistent ductus arteriosus. Br Heart J 1968 ; 30 : 4-13
 
4) Toda, R et al : Operation for adult patent ductus arteriosus using cardiopulmonary bypass. Ann Thorac Surg 2000 ; 70 : 1935-1937
 
5) Akagi, T et al : Coil occlusion of patent ductus arteriosus with detachable coils. Am Heart J 1997 ; 134 : 538-543
 
6) Moore, JW et al : Interventional treatment of patent ductus arteriosus in 2004. Catheter Cardiovasc Interv 2005 ; 64 : 91-101
 
7) Pass, RH et al : Multicenter USA Amplatzer patent ductus arteriosus occulusion device trial : initial and one-year results. J Am Coll Cardiol 2004 ; 44 : 513-519
 
P.150 掲載の参考文献
1) Attenhofer Jost, CH et al : Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly : survival and functional improvement. J Am Coll Cardiol 2012 ; 59 : 2101-2106
 
2) Frescura, C et al : Morphological aspects of Ebstein's anomaly in adults. Thorac Cardiovasc Surg 2000 ; 48 : 203-208
 
3) 椎名由美 : Ebstein病. 成人先天性心疾患, 丹羽公一郎ほか編, メジカルビュー社, 東京, 2015, 171-177
 
4) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
5) Badiu, CC et al : Early timing of surgical intervention in patients with Ebstein's anomaly predicts superior long-term outcome. Eur J Cardiothorac Surg 2010 ; 37 : 186-192
 
6) Lee, CM et al : The shape and function of the right ventricle in Ebstein's anomaly. Int J Cardiol 2013 ; 167 : 704-710
 
7) Warnes, CA et al : ACC/AHA 2008 guidelines for the management of adults with congenital heart disease : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) : Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 : e714-e833
 
8) Silva, JP et al : Cone reconstruction in Ebstein's anomaly repair : early and long-term results. Arq Bras Cardiol 2011 ; 97 : 199-208
 
9) Brown, ML et al : The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg 2008 ; 135 : 1120-1136, 1136.e1-e7
 
10) Brown, ML et al : Functional status after operation for Ebstein anomaly : the Mayo Clinic experience. J Am Coll Cardiol 2008 ; 52 : 460-466
 
P.156 掲載の参考文献
1) Becker, AE et al : Atrioventricular discordance. Pathology of Congenital Heart Disease, Butterworth-Heinemann, Oxford, 1986, 227-234
 
2) Unolt, M et al : Transposition of great arteries : new insights into the pathogenesis. Front Pediatr 2013 ; 1 : 11
PubMed
3) Myers, PO et al : Tricuspid regurgitation or Ebstein dysplasia of the tricuspid valve in congenitally corrected transpositions : Is valvuloplasty necessary at anatomic repair? J Thorac Cardiovasc Surg 2014 ; 147 : 576-580
 
4) Mongeon, FP et al : Congenitally corrected transposition of the great arteries : ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol 2011 ; 57 : 2008-2017
 
5) Imai, Y : Double-switch operation for congenitally corrected transposition of the great arteries. Advances in Cardiac Surgery Vol. 9, Karp, RB ed, Mosby, St. Louis, 1997, 65-86
 
6) Yeo, WT et al : Adverse impact of chronic subpulmonary left ventricular pacing on systemic right ventricular function in patients with congenitally corrected transposition of the great arteries. Int J Cardiol 2014 ; 171 : 184-91
PubMed
7) Khiary, P : Defibrillators and cardiac resynchronization therapy in congenital heart disease : evolving indications. Expert Rev Med Devices 2008 ; 5 : 267-271
 
8) Graham, TP et al : Long-term outcome in congenitally corrected transposition of the great arteries : a multi-institutional study. J Am Coll Cardiol 2000 ; 36 : 255-261
 
9) Yeh, T Jr et al : Atrioventricular discordance : results of repair in 127 patients. J Thorac Cardiovasc Surg 1999 ; 117 : 1190-1203
 
10) Shin'oka, T et al : Outcomes of definitive surgical repair for congenitally corrected transposition of the great arteries or double outlet right ventricle with discordant atrioventricular connections : risk analyses in 189 patients. J Thorac Cardiovasc Surg 2007 ; 133 : 1318-1328
PubMed
P.161 掲載の参考文献
1) Kato, H et al : Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996 ; 94 : 1379-1385
 
2) 牟田広実ほか : 川崎病既往患者の成人期の諸問題. 医学のあゆみ 2010 ; 232 : 802-804
 
3) Sasaguri, Y et al : Regression of aneurysms in Kawasaki disease : a pathological study. J Pediatr 1982 ; 100 : 225-231
 
4) Nakamura, Y et al : Mortality among persons with a history of Kawasaki disease in Japan : mortality among males with cardiac sequelae is significantly higher than that of the general population. Circ J 2008 ; 72 : 134-138
 
5) Muta, H et al : Health-related quality of life in adolescents and young adults with a history of Kawasaki disease. J Pediatr 2010 ; 156 : 439-443
 
6) 高橋啓ほか : 心血管後遺症遠隔期冠動脈病変 : 病理. 小児科臨床ピクシス, 川崎病のすべて, 中山書店, 東京, 2009, 152-153
 
7) Yamakawa, R et al : Coronary endothelial dysfunction after Kawasaki disease : evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998 ; 31 : 1074-1080
 
8) Iemura, M et al : Long term consequences of regressed coronary aneurysms after Kawasaki disease : vascular wall morphology and function. Heart 2000 ; 83 : 307-311
 
9) Mitani, Y et al : Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease : association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005 ; 111 : 38-43
 
10) Sugahara, Y et al : Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 2008 ; 29 : 398-401
 
11) Suda, K et al : Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms : a single-institution experience. Circulation 2011 ; 123 : 1836-1842
 
12) Ishii, M et al : Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease : quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002 ; 105 : 3004-3010
 
13) Muta, H et al : Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 2010 ; 157 : 120-126
 
P.167 掲載の参考文献
1) 内田敬子 : 大動脈弓の発生とその異常. 先天性心疾患を理解するための臨床心臓発生学, 山岸敬幸ほか編, メジカルビュー社, 東京, 2007, 143-150
 
2) Niwa, K : Aortopathy in congenital heart disease in adults : aortic dilatation with decreased aortic elasticity that impacts negatively on left ventricular function. Korean Circ J 2013 ; 43 : 215-220
 
3) Warnes, CA et al : ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008 ; 118 : e714-e833
 
4) 2014年版先天性心疾患, 心臓大血管の構造的疾患 (structural heart disease) に対するカテーテル治療のガイドライン. http://www.j-circ.or.jp/guideline/pdf/JCS2014_nakanishi_h.pdf (2015年3月閲覧)
 
5) Hu, ZP et al : Outcomes of surgical versus balloon angioplasty treatment for native coarctation of the aorta : a meta-analysis. Ann Vasc Surg 2014 ; 28 : 394-403
 
6) Canniffe, C et al : Hypertension after repair of aortic coarctation-a systematic review. Int J Cardiol 2013 ; 167 : 2456-2461
 
7) 村上智明 : 大動脈縮窄の手術後-二次性高血圧-. 新・心臓病診療プラクティス18 大人になった先天性心疾患, 新垣義夫ほか編, 文光堂, 東京, 2012, 259-262
 
8) Chen, SS et al : Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair. Int J Cardiol 2014 ; 173 : 209-215
PubMed
9) Choudhary, P et al : Late outcomes in adults with coarctation of the aorta. Heart 2015 [Epub ahead of print]
 
10) Rosenthal, E : Coarctation of the aorta from fetus to adult : curable condition or life long disease process? Heart 2005 ; 91 : 1495-1502
PubMed
11) Jenkins, NP et al : Coarctation of the aorta : natural history and outcome after surgical treatment. QJM 1999 ; 92 : 365-371
 
P.173 掲載の参考文献
1) Keane, MG et al : Medical management of Marfan syndrome. Circulation 2008 ; 117 : 2802-2813
 
2) Judge, DP et al : Marfan's syndrome. Lancet 2005 ; 366 : 1965-1976
 
3) Loeys, BL et al : The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010 ; 47 : 476-485
 
4) Dietz, HC : Marfan Syndrome. GeneReview(R) NCBI Bookshelf 5) Habashi, JP et al : Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006 ; 312 : 117-121
 
6) Lacro, RV et al : Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med 2014 ; 371 : 2061-2071
 
7) Coselli, JS et al : Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome : a prospective, multicenter, comparative study. J Thorac Cardiovasc Surg 2014 ; 147 : 1758-1766
 
8) Maron, BJ et al : Task force 4 : HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 2005 ; 45 : 1340-1345
 
9) 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf (2015年9月閲覧)
 
10) Baumgartner, H et al : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
11) Curry, RA et al : Marfan syndrome and pregnancy : maternal and neonatal outcomes. BJOG 2014 ; 121 : 610-617
 

IV 成人先天性心疾患に対する最新の治療

P.182 掲載の参考文献
1) O'Connor, CM et al : Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure : insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999 ; 138 (1 Pt 1) : 78-86
 
2) Felker, GM et al : Heart failure etiology and response to milrinone in decompensated heart failure : results from the OPTIME-CHF study. J Am Coll Cardiol 2003 ; 41 : 997-1003
 
3) Elkayam, U et al : Renal vasodilatory action of dopamine in patients with heart failure : magnitude of effect and site of action. Circulation 2008 ; 117 : 200-205
 
4) Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J 2001 ; 141 : 266-273
 
5) Lindenfeld, J et al : HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010 ; 16 : e1-e194
 
6) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997 ; 336 : 525-533
 
7) Wilcox, CS et al : Na+, K+, and BP homeostasis in man during furosemide : effects of prazosin and captopril. Kidney Int 1987 ; 31 : 135-141
 
8) Eshaghian, S et al : Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006 ; 97 : 1759-1764
 
9) Felker, GM et al : Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011 ; 364 : 797-805
 
10) Rudy, DW et al : Loop diuretics for chronic renal insufficiency : a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991 ; 115 : 360-366
 
11) Masuyama, T et al : Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J 2012 ; 76 : 833-842
 
12) Cosin, J et al : Torasemide in chronic heart failure : results of the TORIC study. Eur J Heart Fail 2002 ; 4 : 507-513
 
13) Gheorghiade, M et al : Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007 ; 167 : 1998-2005
 
14) Gheorghiade, M et al : Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure : an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007 ; 28 : 980-988
 
15) Imamura, T et al : Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients ─ association between non-responders and chronic kidney disease. Circ J 2013 ; 77 : 397-404
 
16) Baumgartner, H et al : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
17) Haddad, F et al : Right ventricular function in cardiovascular disease, Part I : anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008 ; 117 : 1436-1448
 
18) Haddad, F et al : Right ventricular function in cardiovascular disease, Part II : pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008 ; 117 : 1717-1731
 
19) Hsu, DT et al : Changing indications for pediatric heart transplantation : complex congenital heart disease. Circulation 2015 ; 131 : 91-99
 
20) Yoshimura, M et al : Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Heart 1994 ; 72 : 528-533
 
P.188 掲載の参考文献
1) Diller, GP et al : Exercise intolerance in adult congenital heart disease : comparative severity, correlates, and prognostic implication. Circulation 2005 ; 112 : 828-835
 
2) Inuzuka, R et al : Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 2012 ; 125 : 250-259
 
3) 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_nohara_h.pdf (2015年9月閲覧)
 
4) Piepoli, MF et al : Exercise training meta-analysis of trials in patients with chronic heart failure (Ex-TraMATCH). BMJ 2004 ; 328 : 189-192
 
5) Lunt, D et al : Physical activity levels of adolescents with congenital heart disease. Aust J Physiother 2003 ; 49 : 43-50
 
6) Dua, JS et al : Physical activity levels in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil 2007 ; 14 : 287-293
 
7) Budts, W et al : Physical activity in adolescents and adults with congenital heart defects : individualized exercise prescription. Eur Heart J 2013 ; 34 : 3669-3674
 
8) O'Connor, CM et al : Efficacy and safety of exercise training in patients with chronic heart failure : HF-ACTION randomized controlled trial. JAMA 2009 ; 301 : 1439-1450
 
P.193 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
2) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators : Preliminary report : effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989 ; 321 : 406-412
 
3) The Cardiac Arrhythmia Suppression Trial II Investigators : Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992 ; 327 : 227-233
 
4) Waldo, AL et al : Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996 ; 348 : 7-12
 
5) 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf (2015年9月閲覧)
 
6) 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). 心房細動治療 (薬物) ガイドライン (2013年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf (2015年9月閲覧)
 
7) Khairy, P et al : PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014 ; 11 : e102-e165
 
P.198 掲載の参考文献
1) Akca, F et al : Acute and long-term outcomes of catheter ablation using remote magnetic navigation in patients with congenital heart disease. Am J Cardiol 2012 ; 110 : 409-414
 
2) Khairy, P et al : PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol 2014 ; 30 : e1-e63
 
3) Yap, SC et al : Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease : negative impact of age and complex atrial surgery. J Am Coll Cardiol 2010 ; 56 : 1589-1596
 
4) Shivapour, JK et al : Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm 2014 ; 11 : 182-186
 
5) Roten, L et al : Catheter ablation of arrhythmias in Ebstein's anomaly : a multicenter study. J Cardiovasc Electrophysiol 2011 ; 22 : 1391-1396
 
6) Khairy, P et al : Cardiac arrhythmias in congenital heart diseases. Indian Pacing Electrophysiol J 2009 ; 9 : 299-317
 
7) Kapel, GF et al : Re-entry using anatomically determined isthmuses : a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol 2015 ; 8 : 102-109
 
8) Sherwin, ED et al : Update on interventional electrophysiology in congenital heart disease : evolving solutions for complex hearts. Circ Arrhythm Electrophysiol 2013 ; 6 : 1032-1040
 
P.204 掲載の参考文献
1) Warnes, CA : Transposition of the great arteries. Circulation 2006 ; 114 : 2699-2709
 
2) Maki, H et al : Initial and programmed combination therapy with oral drugs for severe idiopathic pulmonary arterial hypertension. Int Heart J 2011 ; 52 : 323-326
 
2) 石塚尚子ほか : 修正大血管転位症の成人期臨床像. 心臓 1995 ; 27 : 970-976
 
3) Khairy, P et al : PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014 ; 11 : e102-e165
 
3) Ogawa, A et al : Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan. Life Sci 2014 ; 118 : 414-419
 
4) van Gelder, BM et al : Transseptal endocardial left ventricular pacing : an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm 2007 ; 4 : 454-460
 
4) Sitbon, O et al : Upfront triple combination therapy in pulmonary arterial hypertension : A pilot study. Eur Respir J 2014 ; 43 : 1691-1697
 
5) Calvo, N et al : Endocardial left ventricular lead placement from the left subclavian vein approach. Europace 2014 ; 16 : 1857-1859
 
5) Akagi, S et al : Catecholamine support at the initiation of epoprostenol therapy in pulmonary arterial hypertension. Ann Am Thorac Soc 2014 ; 11 : 719-727
 
6) Rademakers, LM et al : Mid-term follow up of thromboembolic complications in left ventricular endocardial cardiac resynchronization therapy. Heart Rhythm 2014 ; 11 : 609-613
 
6) Fujino, T et al : Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension. Int Heart J 2015 ; 56 : 86-93
 
7) Kriebel, T et al : ICD Implantation in infants and small children : the extracardiac technique. Pacing Clin Electrophysiol 2006 ; 29 : 1319-1325
 
7) Simonneau, G et al : Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013 ; 62 : D34-D41
 
8) Kowalski, M et al : An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart. Heart Rhythm 2010 ; 7 : 1572-1577
PubMed
8) Myers, PO et al : Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ J 2014 ; 78 : 4-11
 
9) Cannon, BC et al : Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart. Pacing Clin Electrophysiol 2006 ; 29 : 181-187
 
9) Tahara, N et al : Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan. Int J Cardiol 2012 ; 158 : e38-e40
 
10) Burke, MC et al : Safety and efficacy of the totally subcutaneous implantable defibrillator : 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol 2015 ; 65 : 1605-1615
 
10) Bradley, EA et al : Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure. Am J Cardiol 2013 ; 112 : 1471-1476
 
11) Galie, N et al : BREATHE-5 : Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology. Chest 2005 ; 128 : 496S
 
12) Mukhopadhyay, S et al : Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome-a randomized, placebo-controlled, double-blind crossover study. Congenit Heart Dis 2011 ; 6 : 424-431
 
13) Zhang, ZN et al : Oral sildenafil treatment for Eisenmenger syndrome : A prospective, open-label, multicentre study. Heart 2011 ; 97 : 1876-1881
 
14) D'Alto, M et al : Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. Int J Cardiol 2012 ; 155 : 378-382
 
15) Dimopoulos, K et al : Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010 ; 121 : 20-25
 
16) Iversen, K et al : Combination therapy with bosentan and sildenafil in Eisenmenger syndrome : A randomized, placebo-controlled, double-blinded trial. Eur Heart J 2010 ; 31 : 1124-1131
 
P.211 掲載の参考文献
1) Yao, A : Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension. J Cardiol 2012 ; 60 : 344-349
 
P.216 掲載の参考文献
1) The Registry for the International Society for Heart and Lung Transplantation : Adult Lung Transplantation Statistics 2014. https://www.ishlt.org/registries/slides.asp?slides=heartLungRegistry
 
2) Simonneau, G et al : Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013 ; 62 (25 Suppl) : D34-D41
 
3) D'Alto, M et al : Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome : current advanced management strategies. Heart 2014 ; 100 : 1322-1328
 
4) Baumgartner, H et al : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
5) Myers, PO et al : Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ J 2014 ; 78 : 4-11
 
6) Aokage, K et al : Living-donor lobar lung transplantation and closure of atrial septal defect for adult Eisenmenger's syndrome. J Heart Lung Transplant 2009 ; 28 : 1107-1109
 
7) Eberlein, M et al : An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2013 ; 32 : 1172-1178
 
8) Waddell, TK et al : Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002 ; 21 : 731-737
 
9) Sato, M et al : Registry of the Japanese Society of Lung and Heart-Lung Transplantation : official Japanese lung transplantation report, 2014. Gen Thorac Cardiovasc Surg 2014 ; 62 : 594-601
 

V 成人先天性心疾患の妊娠・出産

P.223 掲載の参考文献
1) Karamermer, Y et al : Pregnancy and adult congenital heart disease. Expert Rev Cardiovasc Ther 2007 ; 5 : 859-869
 
2) McLeau, KC et al : Tissue factor-dependent thrombin generation across pregnancy. Am J Obstet Gynecol 2012 ; 207 : 135.e1-6
 
3) Estelles, A et al : Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991 ; 165 : 138-142
 
4) Gabbe, SG et al : Obstetrics Normal and Problem Pregnancies, Churchill Livingstone, New York, 1996
 
5) 循環器病の診断と治療に関するガイドライン (2009年合同研究班報告). 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010.niwa.h.pdf (2015年9月閲覧)
 
6) Therrien, J et al : CCS Consensus Conference 2001 update : recommendations for the management of adults with congenital heart disease-Part I. Can J Cardiol 2001 ; 17 : 940-959
 
7) Therrien, J et al : Canadian Cardiovascular Society Consensus Conference 2001 update : recommendations for the management of adults with congenital heart disease-Part II. Can J Cardiol 2001 ; 17 : 1029-1050
 
8) Therrien, J et al : Canadian Cardiovascular Society Consensus Conference 2001 update : recommendations for the management of adults with congenital heart disease-Part III. Can J Cardiol 2001 ; 17 : 1135-1158
 
9) Perloff, JK et al : Pregnancy and congenital heart disease : the mother and the fetus. Congenital Heart Disease in Adults, 2nd ed, Perloff, JK et al eds, WB Saunders, Philadelphia, 1998, 144-164
 
10) Thorne, S et al : Risks of contraception and pregnancy in heart disease. Heart 2006 ; 92 : 1520-1525
 
11) Samuel, C et al : Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001 ; 104 : 515-521
 
12) Drenthen, W et al : Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010 ; 31 : 2124-2132
 
13) Miller, RW : Discussion : severe mental retardation and cancer among atomic bomb survivors exposed in utero. Teratology 1999 ; 59 : 234-235
 
14) Bolt, WJ et al : Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki. Radiology 1973 ; 106 : 617-619
 
15) Regitz-Zagrosek, V et al : ESC Guidelines on the management of cardiovascular diseases during pregnancy : The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011 ; 32 : 3147-3197
 
16) Itabashi, K et al : Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics 2009 ; 123 : 445-450
 
17) Petrini, JR et al : Increased risk of adverse neurological development for late preterm infants. J Pediatr 2009 ; 154 : 169-176
 
18) Tanaka, H et al : Cardiovascular events in pregnancy with hypertrophic cardiomyopathy. Circ J 2014 ; 78 : 2501-2506
 
P.228 掲載の参考文献
1) 循環器病ガイドシリーズ. 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2010年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf (2015年9月閲覧)
 
2) Regitz-Zagrosek, V et al : ESC Guidelines on the management of cardiovascular diseases during pregnancy : The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011 ; 32 : 3147-3197
 
3) Report of the British Cardiac Society Working Party : Grown-up congenital heart (GUCH) disease : current needs and provision of service for adolescents and adults with congenital heart disease in the UK. Heart 2002 ; 88 (Suppl I) : i1-i14
 
4) Siu, SC at al : Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002 ; 105 : 2179-2184
 
5) Iserin, L : Management of pregnancy in women with congenital heart disease. Heart 2001 ; 85 : 493-494
 
6) Hirsh, J et al : American heart association/American college of cardiology foundation guide to warfarin therapy. Circulation 2003 ; 107 : 1692-1711
 
7) Drenthen, W et al : Pregnancy and delivery in women after Fontan palliation. Heart 2006 ; 92 : 1290-1294
 
P.233 掲載の参考文献
1) Robson, SC et al : Cardiac output during labour. Br Med J (Clin Res Ed) 1987 ; 295 : 1169-1172
 
2) Baum, VC et al : Anesthetic implications of adults with congenital heart disease. Anesth Analg 1993 ; 76 : 1342-1358
 
3) Perloff, JK et al : Pregnancy and congenital heart disease : the mother and the fetus. Congenital Heart Disease in Adults, 2nd ed, Saunders, Philadelphia, 1998, 144-164
 
4) Gaiser, R : Physiology changes of pregnancy. Chestnut's Obstetric Anesthesia : Principle and Practice, 5th ed, Elsevier, Philadelphia, 2014, 15-38
 
5) 照井克生監訳 : BWH産科の麻酔, メディカル・サイエンス・インターナショナル, 東京, 1997, 3
 
6) Mazze, RI et al : Reproductive outcome after anesthesia and operation during pregnancy : a registry study of 5405 cases. Am J Obstet Gynecol 1989 ; 161 : 1178-1185
 
7) Duncan, PG et al : Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986 ; 64 : 790-794
 
8) Maxwell, BG et al : Peripartum outcomes and anaesthetic management of parturients with moderate to complex congenital heart disease or pulmonary hypertension. Anaesthesia 2013 ; 68 : 52-59
PubMed
9) 循環器病の診断と治療に関するガイドライン (2009年合同研究班報告). 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010.niwa.h.pdf (2015年9月閲覧)
 
P.238 掲載の参考文献
1) 循環器病ガイドシリーズ. 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2010年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf (2015年9月閲覧)
 
2) 母体安全への提言 2013. 妊産婦死亡症例検討評価委員会, 日本産婦人科医会, 2014
 
3) Trussell, J : Contraceptive efficacy. In Contraceptive Technology, Eighteenth Revised Edition, Hatcher RA et al eds, New York Ardent Media, 2004
 
4) 大久保智治ほか : 12. 避妊法, E. 婦人科疾患の診断・治療・管理. 日産婦誌 2009 ; 61 : N-510-N-519
 
5) World Health Organization (WHO) : Medical eligibility criteria for contraceptive use. Switzerland, Geneva, WHO, 2004
 
6) Silversides, CK et al : Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 2009 ; 11 : 298-305
 
7) Committee on Safety of Medicines (CSM) : Combined oral contraceptives containing desogestrel or gestodene and the risk of venous thromboembolism. Current Problems in Pharmacovigilance 1999 ; 25 : 1-2
 
8) 「低用量経口避妊薬の使用に関するガイドライン」改訂検討委員会 : 低用量経口避妊薬の使用に関するガイドライン, 第2版, 2006
 
9) World Health Organization (WHO) : WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestogens in low oestrogen containing oral contraceptives on venous thromboembolism. Lancet 1995 ; 346 : 1582-1588
 
10) Jick, H et al : Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995 : cohort and case-control analysis. BMJ 2000 ; 321 : 1190-1195
 
11) Lidegaard, O et al : Oral contraceptives and venous thromboembolism : a five year national case-control study. Contraception 2002 ; 65 : 187-196
 
12) Suissa, S et al : First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 1997 ; 56 : 141-146
 
13) El Gebeily, G et al : Estrogen regulation of the transient outward K+ current involves estrogen receptor α in mouse heart. J Mol Cell Cardiol 2015 ; 86 : 85-94
 
14) Sedlak, T et al : Oral contraceptive use and the ECG : evidence of an adverse QT effect on corrected QT interval. Ann Noninvasive Electrocardiol 2013 ; 18 : 389-398
 
15) Ellison, J et al : Drug Points : Apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ 2000 ; 321 : 1382
PubMed
16) Delvigne, A et al : Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS) : a review. Hum Reprod Update 2002 ; 8 : 559-577
 
17) Schenker, JG et al : Ovarian hyperstimulation syndrome : A current survey. Fertil Steril 1978 ; 30 : 255-268
 
18) Brinsden, PR et al : Diagnosis, prevention, and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995 ; 102 : 767-772
 
19) Gervasi, G et al : Ischemic stroke after ovulation induction in a patient with cardiac and thrombophilic abnormalities. Eur J Obstet Gynecol Reprod Biol 2012 ; 162 : 119-120
 

VI 成人先天性心疾患の全身管理

P.246 掲載の参考文献
1) Niwa, K et al : Infective endocarditis in congenital heart disease : Japanese national collaboration study. Heart 2005 ; 91 : 795-800
 
2) Durack, DT et al : New criteria for diagnosis of infective endocarditis : utilization of specific echocardiographic findings. Am J Med 1994 ; 96 : 200-209
 
3) Wilson, W et al : Prevention of infective endocarditis : guidelines from the American Heart Association : a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007 ; 116 : 1736-1754
 
4) Dajani, AS et al : Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997 ; 277 : 1794-1801 (Circulation 1997 ; 96 : 358-366)
 
5) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
6) Habib, G et al : Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009) : the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009 ; 30 : 2369-2413
 
7) 循環器病の診断と治療に関するガイドライン (2007年度合同研究班報告). 感染性心内膜炎の予防と治療に関するガイドライン (2008年改訂版). http://www.jcirc.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf (2015年9月閲覧)
 
8) Ferrieri, P et al : Unique features of infective endocarditis in childhood. Circulation 2002 ; 105 : 2115-2126
 
9) Bayer, AS et al : Diagnosis and management of infective endocarditis and its complication. Circulation 1998 ; 98 : 2936-2948
 
10) Thuny, F et al : Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis : a prospective multicentre study. Eur Heart J 2007 ; 28 : 1155-1161
 
11) Eishi, K et al : Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995 ; 110 : 1745-1755
 
12) Corr, P et al : Endocarditis-related cerebral aneurysms : radiologic changes with treatment. AJNR Am J Neuroradiol 1995 ; 16 : 745-748
 
P.251 掲載の参考文献
1) Shiina, Y et al : Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011 ; 146 : 13-16
 
2) Warnes, CA et al : ACC/AHA 2008 guidelines for the management of adults with congenital heart disease : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008 ; 118 : 2395-2451
 
3) Ramakrishna, G et al : Impact of pulmonary hypertension on the outcomes of noncardiac surgery : predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005 ; 45 : 1691-1699
 
4) Perloff, JK et al : Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 2000 ; 86 : 1198-1204
 
5) Bolger, AP et al : Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002 ; 106 : 92-99
 
6) Tweddell, JS et al : Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg 2007 ; 84 : 1301-1310
 
P.255 掲載の参考文献
1) Warnes, CA et al : ACC/AHA 2008 guidelines for the management of adults with congenital heart disease : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) : Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 : e714-e833
 
2) Kovacs, AH et al : Psychosocial functioning and quality of life in adults with congenital heart disease and heart failure. Heart Fail Clin 2014 ; 10 : 35-42
 
3) Kovacs, AH et al : Depression and anxiety in adult congenital heart disease : predictors and preva lence. Int J Cardiol 2009 ; 137 : 158-164
 
4) Enomoto, J et al : Psychosocial factors influencing mental health in adults with congenital heart disease. Circ J 2013 ; 77 : 749-755
 
5) Apers, S et al : Assessment of Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease-International Study (APPROACHIS) : rationale, design, and methods. Int J Cardiol 2015 ; 179 : 334-342
 
6) Enomoto, J et al : Negative effect of aging on psychosocial functioning of adults with congenital heart disease. Circ J 2014 ; 79 : 185-192
 
7) Marino, BS et al : Neurodevelopmental outcomes in children with congenital heart disease : evaluation and management : a scientific statement from the American Heart Association. Circulation 2012 ; 126 : 1143-1172
 
8) Bellinger, DC et al : Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure : neuropsychological assessment and structural brain imaging. Circulation 2011 ; 124 : 1361-1369
 
9) Cassidy, AR et al : Executive function in children and adolescents with critical cyanotic congenital heart disease. J Int Neuropsychol Soc 2014 ; 21 : 34-49
 
10) Sable, C et al : Best practices in managing transition to adulthood for adolescents with congenital heart disease : the transition process and medical and psychosocial issues : a scientific statement from the American Heart Association. Circulation 2011 ; 123 : 1454-1485
 
11) 横谷進ほか (日本小児科学会移行期の患者に関するワーキンググループ) : 小児期発症疾患を有する患者の移行期医療に関する提言. 日児誌 2014 ; 118 : 98-106
 
12) 丸光惠 : 看護師, 医療スタッフのための『移行期支援ガイドブック』とは. 週刊医学界新聞 2013, 第3019号
 
P.260 掲載の参考文献
1) 厚生労働省 : 平成23年歯科疾患実態調査
 
2) 光岡知足 : 人の健康における腸内細菌フローラコントロールの意義. 腸内フローラと生活習慣病-食生活とのかかわり, 光岡知足編, 学会出版センター, 東京, 2001, 1-40
 
3) 日本歯周病学会編 : 歯周病の検査・診断・治療計画の指針 2008
Medical*Online
4) Gibson, FC 3rd et al : Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004 ; 109 : 2801-2806
 
5) Que, YA et al : Infective endocarditis. Nat Rev Cardiol 2011 ; 8 : 322-336
 
6) Tonetti, MS et al : Treatment of periodontitis and endothelial function. N Engl J Med 2007 ; 356 : 911-920
 
7) Kudo, C et al : Assessment of the plasma/serum IgG test to screen for periodontitis. J Dent Res 2012 ; 91 : 1190-1195
 
8) 日本歯周病学会 (学会見解論文) : 正しい歯周治療の普及をめざして-抗真菌剤の利用を批判する-. 日歯周病会誌 2000 ; 42 : S1-S6
 

VII 成人先天性心疾患の診療体制と今後

P.268 掲載の参考文献
1) Shiina, Y et al : Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011 ; 146 : 13-16
 
2) Niwa, K et al : Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol 2004 ; 96 : 211-216
 
3) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
4) 白石公ほか : 成人先天性心疾患の診療体制確立に向けて. 循環器専門医 2013 ; 21 : 61-69
 
5) 白石公 : 成人先天性心疾患の診療体系の確立をめざして. 京府医大誌 2014 ; 123 : 711-722
 
6) 白石公 : 成人に達した先天性心疾患の診療体制の確立に向けた総合的研究. 厚生労働科学研究補助金事業研究報告書, 2014
 
7) 八尾厚史 : 成人先天性心疾患の診療体制-循環器内科医の立場から. 日成人先天性心疾患会誌 2012 ; 1 : 17-23
 
8) Ochiai, R et al : Status and future needs of regional adult congenital heart disease centers in Japan. Circ J 2011 ; 75 : 2220-2227
 
9) American Board of Medical Specialties. Specialties and Subspecialties. http://www.abms.org/who_we_help/physicians/specialties.aspxm (2015年3月10日閲覧)
 
10) Sable, C et al : Best practices in managing transition to adulthood for adolescents with congenital heart disease : the transition process and medical and psychosocial issues : a scientific statement from the American Heart Association. Circulation 2011 ; 123 : 1454-1485
 
11) Karamlou, T et al : Adults or big kids : what is the ideal clinical environment for management of grown-up patients with congenital heart disease? Ann Thorac Surg 2010 ; 90 : 573-579
 
12) Grant, B et al : Remote diagnosis of congenital heart disease : the impact of telemedicine. Arch Dis Child 2010 ; 95 : 276-280
 
P.272 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2015年9月閲覧)
 
2) Warnes, CA et al : ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) : Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 : e714-e833
 
3) Baumgartner, H et al : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) : The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010 ; 31 : 2915-2957
 
4) Niwa, K et al : Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol 2004 ; 96 : 211-216
 
5) Cassel, CK et al : Specialization, subspecialization, and subsubspecialization in internal medicine. N Engl J Med 2011 ; 364 : 1169-1173
 
6) Fernandes, SM et al : Referral patterns and perceived barriers to adult congenital heart disease care : results of a survey of U.S. pediatric cardiologists. J Am Coll Cardiol 2012 ; 60 : 2411-2418
 
7) Fernandes, SM et al : Adult congenital heart disease incidence and consultation : a survey of general adult cardiologists. J Am Coll Cardiol 2013 ; 61 : 1303-1304
 
8) Mackie, AS et al : Children and adults with congenital heart disease lost to follow-up : who and when? Circulation 2009 ; 120 : 302-309
 

書評

最近チェックした商品履歴

Loading...